Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up
- PMID: 10202056
- DOI: 10.1016/s0016-5107(99)70040-4
Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up
Abstract
Background: Endoscopic ablation of Barrett's esophagus, including associated dysplasia and adenocarcinoma, can be achieved by various techniques, but few long-term results are available. The aim of our study was ablation of intramucosal adenocarcinoma with a combination of Nd:YAG laser plus multipolar electrocoagulation.
Methods: Patients with documented Barrett's esophagus and adenocarcinoma who either had refused surgery or were poor candidates for surgery because of high risk were offered endoscopic therapy. Patients underwent therapy with Nd:YAG laser and multipolar electrocoagulation. They were treated with omeprazole (20 mg twice daily) as maintenance therapy.
Results: Six patients were enrolled in the study over a 7-year period. All were men with a mean age of 78.2 years. The mean length of Barrett's esophagus was 6.0 cm (range, 3 to 10 cm). Seventeen Nd:YAG laser (mean, 2.8/patient) and 20 multipolar electrocoagulation (mean, 3.3/patient) sessions were used during the study period. All patients had a complete initial response to therapy. One patient on chronic immunosuppressive medications had recurrence of the tumor after an initial complete response (36-month follow-up). Two patients have no evidence of Barrett's esophagus, and 3 patients have residual intestinal metaplasia on biopsy of an irregular appearing "neo" Z-line. Mean follow-up in this group is 3.4 years (range, 9 to 86 months).
Conclusions: Laser photocoagulation and multipolar electrocoagulation can be successfully and safely used to ablate intramucosal adenocarcinoma in the setting of Barrett's esophagus. Patients remain functional with normal swallowing.
Similar articles
-
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.Gastrointest Endosc. 1999 Jan;49(1):8-12. doi: 10.1016/s0016-5107(99)70438-4. Gastrointest Endosc. 1999. PMID: 9869716 Clinical Trial.
-
Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.Gastrointest Endosc. 1999 Jan;49(1):1-7. doi: 10.1016/s0016-5107(99)70437-2. Gastrointest Endosc. 1999. PMID: 9869715
-
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.Gastrointest Endosc. 2001 May;53(6):554-8. doi: 10.1067/mge.2001.114418. Gastrointest Endosc. 2001. PMID: 11323578
-
The diagnosis and management of Barrett's esophagus.Adv Surg. 1999;33:29-68. Adv Surg. 1999. PMID: 10572561 Review.
-
Barrett's esophagus: ablative endoscopic techniques.Tumori. 2003 Mar-Apr;89(2):117-21. doi: 10.1177/030089160308900202. Tumori. 2003. PMID: 12841655 Review.
Cited by
-
Limited resection for early esophageal cancer?Langenbecks Arch Surg. 2003 Apr;388(2):88-94. doi: 10.1007/s00423-003-0371-9. Epub 2003 Apr 1. Langenbecks Arch Surg. 2003. PMID: 12684802
-
The evolution of endoscopic therapy for Barrett's esophagus.Ther Adv Gastrointest Endosc. 2021 Oct 22;14:26317745211051834. doi: 10.1177/26317745211051834. eCollection 2021 Jan-Dec. Ther Adv Gastrointest Endosc. 2021. PMID: 34708204 Free PMC article. Review.
-
Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation.World J Surg. 2003 Sep;27(9):1026-9. doi: 10.1007/s00268-003-7056-y. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917762 Review.
-
Management of Barrett's esophageal carcinoma.Surg Today. 2013 Apr;43(4):353-60. doi: 10.1007/s00595-012-0468-2. Epub 2013 Jan 3. Surg Today. 2013. PMID: 23283352 Review.
-
Transoesophageal ultrasound applicator for sector-based thermal ablation: first in vivo experiments.Ultrasound Med Biol. 2003 Feb;29(2):285-91. doi: 10.1016/s0301-5629(02)00701-9. Ultrasound Med Biol. 2003. PMID: 12659916 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical